A Pilot Randomised, Open, Uncontrolled, Clinical Study of Two Dosages of St John’s Wort (Hypericum perforatum) Herb Extract (LI-160) as an Aid to Motivational/Behavioural Support in Smoking Cessation

Abstract

There is an association between smoking and depression, yet the herbal antidepressant St John’s wort (Hypericum perforatum L.; SJW) herb extract has not previously been investigated as an aid in smoking cessation. In this open, uncontrolled, pilot study, 28 smokers of 10 or more cigarettes per day for at least one year were randomised to receive SJW herb extract (LI-160) 300 mg once or twice daily taken for one week before and continued for 3 months after a target quit date. In addition, all participants received motivational/behavioural support from a trained pharmacist. At 3 months, the point prevalence and continuous abstinence rates were both 18 %, and at 12 months were 0 %. Fifteen participants (54 %) reported 23 adverse events up to the end of the 3-month follow-up period. There was no statistically significant difference in the frequency of adverse events for participants taking SJW once or twice daily (p > 0.05). Most adverse events were mild, transient and non-serious. This preliminary study has not provided convincing evidence that a SJW herb extract plus individual motivational/behavioural support is likely to be effective as an aid in smoking cessation. However, it may be premature to rule out a possible effect on the basis of a single, uncontrolled pilot study, and other approaches involving SJW extract may warrant investigation.

References

• 1 Linde K, Mulrow C D, Berner M, Egger M. St John's wort for depression. The Cochrane Database of Systematic Reviews. 2005: Issue 3: Art. No. CD000448. DOI: 10.1002/14 651 858.CD000448.pub2
• 2 Barnes J, Anderson L A, Phillipson J D. St John’s wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.  J Pharm Pharmacol. 2001;  53 583-600
• 3 Butterweck V. Mechanism of action of St John’s wort in depression: what is known?.  CNS Drugs. 2003;  17 539-62
• 4 Hughes J R, Stead L F, Lancaster T. Antidepressants for smoking cessation. The Cochrane Database of Systematic Reviews. 2004: Issue 4: Art. No. CD000031. DOI: 10.1002/14 651 858.CD000031.pub2
• 5 Hurt R D, Sachs D PL, Glover E D, Offord K P, Johnston J A, Dale L C. et al . A comparison of sustained-release bupropion and placebo for smoking cessation.  New Eng J Med. 1997;  337 1195-202
• 6 Jorenby D E, Leischow S J, Nides M A, Rennard S I, Johnston J A, Hughes A R. et al . A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.  New Eng J Med. 1999;  340 685-91
• 7 Anon . Zyban [bupropion (amfebutamone)] - safety reminder.  Curr Probl Pharmacovigilance. 2001;  27 5
• 8 Ernst E, Rand J I, Barnes J, Stevinson C. Adverse effects profile of the herbal antidepressant St John's wort (Hypericum perforatum L.)  Eur J Clin Pharmacol. 1998;  54 589-94
• 9 Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. The Cochrane Database of Systematic Reviews. 2004: Issue 3: Art. No. CD000146. DOI: 10.1002/14 651 858. CD000146.pub2
• 10 Lancaster T, Stead L F. Individual behavioural counselling for smoking cessation. The Cochrane Database of Systematic Reviews. 2002: Issue 3: Art. No. CD001292. DOI: 10.1002/14 651 858.CD001292
• 11 Coleman T. ABC of smoking cessation. Special groups of smokers.  BMJ. 2004;  328 575-7
• 12 Prochazka A V, Weaver M J, Keller R T, Fryer G E, Licari P A, Lofaso D A. A randomized trial of nortriptyline for smoking cessation.  Arch Intern Med. 1998;  158 2035-9
• 13 Catania M A, Firenzuoli F, Crupi A, Mannucci C, Caputi A P, Calapai G. Hypericum perforatum attenuates nicotine withdrawal signs in mice.  Psychopharmacology. 2003;  169 186-9
• 14 Lee H J, Lee J H. Effects of medicinal herb tea on the smoking cessation and reducing smoking withdrawal symptoms.  Am J Chin Med. 2005;  33 127-38
• 15 Prochaska J O, DiClemente C C. Stages and processes of self-change of smoking: toward an integrative model of change.  J Consult Clin Psychol. 1983;  51 390-5